With other COVID-19 treatments ineffective against the variant or in short supply, the FDA is expanding its approval of Veklury to include outpatient use.
Show CommentsClose Comments
With other COVID-19 treatments ineffective against the variant or in short supply, the FDA is expanding its approval of Veklury to include outpatient use.